Thomas R. Kuhn
CIK: 0001571521
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Anterix Inc.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Aug 24, 2026ATEX
Anterix Inc.
Sale(S)Direct400 shares at avg. $91.01$36K - Aug 24, 2026ATEX
Anterix Inc.
Exercise(M)Direct10K shares at avg. $33.62$336K - Aug 24, 2026ATEX
Anterix Inc.
Sale(S)Direct4.4K shares at avg. $88.18$387K - Aug 24, 2026ATEX
Anterix Inc.
Sale(S)Direct4.4K shares at avg. $89.12$394K - Aug 24, 2026ATEX
Anterix Inc.
Sale(S)Direct790 shares at avg. $90.00$71K - Jun 18, 2026ATEX
Anterix Inc.
Sale(S)Direct1.7K shares at avg. $79.52$132K - May 20, 2026ATEX
Anterix Inc.
Award(A)Direct2.8K shares- - Jun 12, 2025ATEX
Anterix Inc.
Award(A)Direct6.2K shares- - Jan 22, 2025ATEX
Anterix Inc.
Award(A)DirectStock Option (Right to Buy)
56.8K shares- - Dec 26, 2024ATEX
Anterix Inc.
Award(A)DirectStock Option (Right to Buy)
7.1K shares- - Dec 26, 2024ATEX
Anterix Inc.
Award(A)DirectStock Option (Right to Buy)
61.8K shares- - Dec 5, 2024ATEX
Anterix Inc.
Award(A)Direct6.5K shares- - Dec 5, 2024ATEX
Anterix Inc.
Award(A)Direct6.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 24, 2026 | ATEX Anterix Inc. | Sale(S) | 400 | $91.01 | $36,404 | Direct |
| Aug 24, 2026 | ATEX Anterix Inc. | Exercise(M) | 10,000 | $33.62 | $336,200 | Direct |
| Aug 24, 2026 | ATEX Anterix Inc. | Sale(S) | 4,392 | $88.18 | $387,295 | Direct |
| Aug 24, 2026 | ATEX Anterix Inc. | Sale(S) | 4,418 | $89.12 | $393,726 | Direct |
| Aug 24, 2026 | ATEX Anterix Inc. | Sale(S) | 790 | $90.00 | $71,101 | Direct |
| Jun 18, 2026 | ATEX Anterix Inc. | Sale(S) | 1,654 | $79.52 | $131,526 | Direct |
| May 20, 2026 | ATEX Anterix Inc. | Award(A) | 2,791 | - | $0 | Direct |
| Jun 12, 2025 | ATEX Anterix Inc. | Award(A) | 6,222 | - | - | Direct |
| Jan 22, 2025 | ATEX Anterix Inc. | Award(A) Stock Option (Right to Buy) | 56,803 | - | - | Direct |
| Dec 26, 2024 | ATEX Anterix Inc. | Award(A) Stock Option (Right to Buy) | 7,108 | - | - | Direct |
| Dec 26, 2024 | ATEX Anterix Inc. | Award(A) Stock Option (Right to Buy) | 61,804 | - | - | Direct |
| Dec 5, 2024 | ATEX Anterix Inc. | Award(A) | 6,474 | - | $0 | Direct |
| Dec 5, 2024 | ATEX Anterix Inc. | Award(A) | 6,574 | - | $0 | Direct |
1-13 of 13 transactions
About Kuhn Thomas R.
Kuhn Thomas R. (SEC CIK 0001571521) files insider reports with the SEC as Director of Anterix Inc. (ATEX).
Signal8 holds 7 ownership filings by Kuhn Thomas R., all Form 4s, filed between Dec 9, 2024 and Aug 26, 2026. Those filings report 13 transactions, from Dec 5, 2024 to Aug 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kuhn Thomas R.'s filings is in WOODLAND PARK, NJ.
Recent filings by Kuhn Thomas R.
- Aug 24, 2026: Open-market sale of ATEX shares (Form 4, code S).
- Aug 24, 2026: Option exercise of ATEX shares (Form 4, code M).
- Aug 24, 2026: Open-market sales of ATEX shares (3 lines, Form 4, code S).
- Jun 18, 2026: Open-market sale of ATEX shares (Form 4, code S).
- May 20, 2026: Grant or award of ATEX shares (Form 4, code A).
Other insiders filing for Anterix Inc. (ATEX)
- Marquez Elena, Chief Financial Officer
- Lang Scott A., President and CEO
- Martin Heather, Chief Marketing Officer
- Ashe Gena L, Chief Legal Officer & Corp Sec
- DANIELS LESLIE B, Director
- Guttman-McCabe Christopher, Chief Reg & Comm Officer